Department of Ultrasound, Tianjin Third Central Hospital, Tianjin, China.
Clin Radiol. 2013 Jun;68(6):608-15. doi: 10.1016/j.crad.2012.12.008. Epub 2013 Feb 8.
To investigate the common complications of thermal ablation of liver tumours using both radiofrequency ablation (RFA) and microwave ablation (MWA) techniques, and to compare the safety of these two procedures.
This retrospective study protocol was approved by the institution's ethics committee to allow investigators to review existing patient medical records. A total of 879 patients with hepatic tumours underwent thermal ablation; 323 patients underwent RFA and 556 underwent MWA. The complications of the RFA and MWA techniques were compared.
A total of 1030 thermal ablation sessions was performed in 879 patients with a total of 1652 tumours. Three hundred and twenty-three patients with 562 tumours received a total of 376 RFA sessions with an average of 1.16 ± 0.48 sessions per patient. The other 556 patients with 1090 tumours received a total of 654 MWA with an average 1.18 ± 0.51 sessions per patient. The mortality rates were 0.31% (1/323) and 0.36% (2/556) in RFA and MWA group. In RFA and MWA group, the major complication rates were 3.5% (13/376) and 3.1% (20/654), meanwhile the minor complication rates were 5.9% (22/376) and 5.7% (37/654). There was no statistically significant difference in the mortality rates, major complications, and minor complications between the RFA and MWA groups (p > 0.05).
Thermal ablation therapy in the treatment of liver cancers is relatively safe with low mortality and a low incidence of serious complications. The types and incidences of complications caused by RFA and MWA are similar and comparable for safety consideration in clinical settings.
探讨射频消融(RFA)和微波消融(MWA)治疗肝肿瘤的常见并发症,并比较这两种方法的安全性。
本回顾性研究方案经机构伦理委员会批准,允许研究人员查阅现有患者病历。共 879 例肝肿瘤患者接受了热消融治疗;323 例接受 RFA,556 例接受 MWA。比较 RFA 和 MWA 技术的并发症。
879 例患者共进行了 1030 次热消融治疗,共 1652 个肿瘤。323 例患者(562 个肿瘤)共进行了 376 次 RFA,平均每位患者 1.16±0.48 次。另外 556 例患者(1090 个肿瘤)共进行了 654 次 MWA,平均每位患者 1.18±0.51 次。RFA 和 MWA 组的死亡率分别为 0.31%(1/323)和 0.36%(2/556)。在 RFA 和 MWA 组中,主要并发症发生率分别为 3.5%(13/376)和 3.1%(20/654),同时,次要并发症发生率分别为 5.9%(22/376)和 5.7%(37/654)。RFA 和 MWA 组之间的死亡率、主要并发症和次要并发症发生率无统计学差异(p>0.05)。
射频消融治疗肝癌相对安全,死亡率低,严重并发症发生率低。RFA 和 MWA 引起的并发症类型和发生率相似,在临床安全性考虑方面可以相提并论。